Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022

ITM Monkeypox Study Group

Research output: Contribution to journalA1: Web of Science-articlepeer-review

7 Downloads (Pure)

Abstract

Vaccination is important in containing the 2022 mpox (formerly monkeypox) epidemic. We describe five Belgian patients with localised severe symptoms of proctitis and penile oedema, occurring between 4 and 35 days after post-exposure preventive vaccination or after one- or two-dose off-label pre-exposure preventive vaccination with MVA-BN vaccine. Genome sequencing did not reveal evidence for immune escape variants. Healthcare workers and those at risk should be aware of possible infections occurring shortly after vaccination and the need for other preventive measures.

Original languageEnglish
Article number2200894
JournalEurosurveillance
Volume27
Issue number48
Number of pages6
ISSN1560-7917
DOIs
Publication statusPublished - 2022

Keywords

  • Humans
  • Monkeypox/prevention & control
  • Belgium/epidemiology
  • Smallpox Vaccine
  • Vaccination/adverse effects

Fingerprint

Dive into the research topics of 'Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022'. Together they form a unique fingerprint.

Cite this